At the 24th Annual SMSNA Fall Scientific Meeting, Dr. Rachel Rubin spoke on the topic "Couples Approach to Testosterone Therapy," advocating the idea that "couples who testosterone together stay together." While the American Urological Association (AUA) Guideline on Testosterone Deficiency supports testosterone replacement therapy for men with low testosterone levels, Dr. Rubin highlighted the limited support for testosterone therapy in women, particularly in improving their sexual health and overall well-being.
She emphasized that menopause involves more than just hot flashes and night sweats, extending to symptoms such as joint pain, low libido, increased urinary tract infections (UTIs), and even heart palpitations. These diverse symptoms may be linked to decreasing testosterone levels in women entering menopause. Understanding the hormone sensitivity of genital structures, Dr. Rubin shared that testosterone deficiency could lead to problems for women.
The presentation shed light on evidence supporting the effectiveness of testosterone therapy for women in addressing conditions like hypoactive sexual desire disorder (HSDD), hormonally mediated vestibulodynia, and other sexual health issues. Dr. Rubin's insights contribute to the growing understanding of the role of testosterone therapy in enhancing the well-being of both men and women, emphasizing the importance of considering hormonal factors in addressing various aspects of sexual health.